Key result
GDMT score ≥4 at ICU discharge linked to ~75% fewer 6-month events in cardiogenic shock.
Why the study?
Determining the optimal timing for initiating guideline-directed medical therapy in survivors of cardiogenic shock remains a clinical challenge due to balancing early intervention benefits with hemodynamic instability risks.
Does early initiation of guideline-directed medical therapy improve 6-month outcomes in patients with cardiogenic shock supported with Impella?
Observational (n=42)
Yes
Does early initiation of guideline-directed medical therapy improve 6-month outcomes in patients with cardiogenic shock supported with Impella?
Early initiation of guideline-directed medical therapy during ICU stabilization in Impella-supported cardiogenic shock survivors is associated with improved 6-month event-free survival.
Answers are grounded in this paper and cite their sources.
May support GDMT optimization at ICU discharge in cardiogenic shock survivors; hypothesis-generating and requires prospective confirmation before practice change.
BACKGROUND: Determining the optimal timing for initiating guideline-directed medical therapy (GDMT) in survivors of cardiogenic shock remains a clinical challenge. Clinicians must balance the urgency of early intervention to prevent adverse remodeling with the risk of hemodynamic instability. This study tested the hypothesis that initiating GDMT early during the intensive care unit (ICU) stay is associated with improved 6-month clinical outcomes in this high-risk population. METHODS: -supported cardiogenic shock, patients were stratified by their simple GDMT score at ICU discharge (high-score group: score ≥ 4, n = 24 vs. low-score group: score < 4, n = 18). The primary endpoint was a 6-month composite of all-cause mortality and heart failure readmission. RESULTS: The high-score group demonstrated significantly superior 6-month event-free survival compared to the low-score group (log-rank p < 0.001). Additionally, this group achieved higher GDMT scores at hospital discharge (median: 8.0 vs. 2.0, p < 0.001), with a greater proportion achieving a score ≥ 5 (83.3% vs. 27.8%, p < 0.001). CONCLUSION: Our findings suggest that early initiation of GDMT during ICU stabilization is associated with improved 6-month outcomes in survivors of cardiogenic shock. This hypothesis-generating study provides a rationale for future prospective trials to validate this goal-directed strategy.
No takes yet. Share an insight, caveat, or question.
Yokawa et al. (2025) conducted an observational in Cardiogenic shock (n=42). High guideline-directed medical therapy (GDMT) score (≥ 4) at ICU discharge vs. Low GDMT score (< 4) at ICU discharge was evaluated on Composite of all-cause mortality and heart failure readmission within 6 months (p=<0.001). Achieving a guideline-directed medical therapy score of ≥4 at ICU discharge significantly improved 6-month event-free survival in survivors of cardiogenic shock compared to a score <4.
Synapse has enriched 10 related papers. Consider them for comparative context: